The problem is there is no probability with FKA BioAmber. The outcome was known back inn September 2018 when the liquidation of all the assets to LCYB for $4.34 mil was approved. From that point on there was no chance for shareholders to receive any type of monetary compensation for their worthless shares. That is a cold hard fact and no amount of hopes and dreams will change that
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.